Latest filing published 14 Aug 2026 for Edgewise Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Behrad Derakhshan appears in our data through filings on Edgewise Therapeutics, Inc. shares, published by SEC (Form 4). We count 13 filings; the first trade dates from 1 May 2023 and the latest from 12 August 2026.
On the market, this insider has only sold: 4 sales, €194k in total. Other entries cover 9 option exercises. Since January 2026: no purchases and 4 sales on the market.
On 14 August 2026 came the latest disclosure, an option exercise in Edgewise Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations